We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Coursera
COUR
$1.52B
| $1.3M | 0.15% |
+67,023
| New | +$1.28M |
|
202
Vestis
VSTS
$1.91B
| $1.29M | 0.15% |
+61,193
| New | +$1.05M |
|
203
Kroger
KR
$35.4B
| $1.29M | 0.15% |
+28,201
| New | +$1.25M |
|
204
UnitedHealth
UNH
$376B
| $1.28M | 0.15% |
+2,431
| New | +$1.3M |
|
205
Snap-on
SNA
$21.2B
| $1.26M | 0.15% |
4,378
+1,560
| +55% | +$421K |
|
206
National Vision
EYE
$1.77B
| $1.26M | 0.15% |
60,330
+27,612
| +84% | +$490K |
|
|
PINC
207
DELISTED
Premier
PINC
| $1.25M | 0.14% |
55,889
+38,880
| +229% | +$804K |
|
208
Crinetics Pharmaceuticals
CRNX
$8.84B
| $1.24M | 0.14% |
+34,912
| New | +$1.07M |
|
209
Sherwin-Williams
SHW
$82.7B
| $1.24M | 0.14% |
3,974
-7,983
| -67% | -$2.15M |
|
|
PDCO
210
DELISTED
Patterson Companies, Inc.
PDCO
| $1.23M | 0.14% |
+43,327
| New | +$1.28M |
|
211
Enphase Energy
ENPH
$4.96B
| $1.23M | 0.14% |
9,290
+5,862
| +171% | +$622K |
|
212
Advanced Micro Devices
AMD
$776B
| $1.22M | 0.14% |
+8,252
| New | +$973K |
|
213
Procter & Gamble
PG
$336B
| $1.22M | 0.14% |
+8,295
| New | +$1.23M |
|
214
Ryder
R
$9.83B
| $1.21M | 0.14% |
+10,550
| New | +$1.11M |
|
215
Hubbell
HUBB
$25B
| $1.21M | 0.14% |
3,687
+683
| +23% | +$205K |
|
|
GRMN
216
Garmin
GRMN
$56.7B
| $1.2M | 0.14% |
9,363
-9,518
| -50% | -$1.1M |
|
|
WIRE
217
DELISTED
Encore Wire Corp
WIRE
| $1.2M | 0.14% |
+5,630
| New | +$1.07M |
|
218
Sonos
SONO
$1.73B
| $1.2M | 0.14% |
69,982
+4,262
| +6% | +$57.5K |
|
219
Arvinas
ARVN
$518M
| $1.2M | 0.14% |
+29,071
| New | +$680K |
|
220
Jazz Pharmaceuticals
JAZZ
$15.9B
| $1.17M | 0.14% |
+9,529
| New | +$1.19M |
|
221
Ingredion
INGR
$6.27B
| $1.17M | 0.13% |
+10,740
| New | +$1.08M |
|
222
PPG Industries
PPG
$24.6B
| $1.16M | 0.13% |
7,781
-30,881
| -80% | -$4.18M |
|
223
Rambus
RMBS
$9.87B
| $1.16M | 0.13% |
+16,999
| New | +$1.06M |
|
224
Choice Hotels
CHH
$5.07B
| $1.16M | 0.13% |
+10,237
| New | +$1.17M |
|
225
FIGS
FIGS
$1.79B
| $1.16M | 0.13% |
166,577
+116,650
| +234% | +$772K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.